152 related articles for article (PubMed ID: 3497139)
21. Cellular and serological subtypes of HLA-DR2.
Freidel AC; Betuel H; Gebuhrer L; Farre A; Lambert J
Tissue Antigens; 1987 Mar; 29(3):129-40. PubMed ID: 2955548
[TBL] [Abstract][Full Text] [Related]
22. Narcolepsy-cataplexy in Israeli Jews is associated exclusively with the HLA DR2 haplotype. A study at the serological and genomic level.
Wilner A; Steinman L; Lavie P; Peled R; Friedmann A; Brautbar C
Hum Immunol; 1988 Jan; 21(1):15-22. PubMed ID: 2896649
[TBL] [Abstract][Full Text] [Related]
23. [Two-dimensional gel analyses of HLA-D region antigens by the use of monoclonal antibodies].
Takenouchi T
Hokkaido Igaku Zasshi; 1983 May; 58(3):279-91. PubMed ID: 6194092
[TBL] [Abstract][Full Text] [Related]
24. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
[TBL] [Abstract][Full Text] [Related]
25. Class II major histocompatibility complex restriction of human T cell responses to short ragweed allergen, Amb a V.
Huang SK; Zwollo P; Marsh DG
Eur J Immunol; 1991 Jun; 21(6):1469-73. PubMed ID: 2044656
[TBL] [Abstract][Full Text] [Related]
26. HLA-D clusters associated with DR2 and the definition of HLA-D"AZH": a new DR2 related HLA-D specificity in Israel.
Cohen N; Amar A; Oksenberg JR; Brautbar C
Tissue Antigens; 1984 Jul; 24(1):1-9. PubMed ID: 6207623
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms within the HLA-DRw6 haplotype. III. DQ alpha and DQ beta polymorphism associated with HLA-D.
Bosch ML; Fei H; Bontrop RE; Gerrets R; Tilanus MG; Termijtelen A; Giphart MJ
Hum Immunol; 1987 Jun; 19(2):91-103. PubMed ID: 3038800
[TBL] [Abstract][Full Text] [Related]
28. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
[TBL] [Abstract][Full Text] [Related]
29. HLA-DR restriction-fragment-length polymorphisms in narcolepsy.
Holloman JD; Bell JI; Kilduff TS; Dement WC; Guilleminault C; McDevitt HO
J Neurosci Res; 1987; 18(1):239-44. PubMed ID: 2890770
[TBL] [Abstract][Full Text] [Related]
30. RFLP analysis of HLA-DR and -DQ genes and their linkage relationships in the Pacific.
Kohonen-Corish MR; Serjeantson SW
Am J Hum Genet; 1986 Dec; 39(6):751-62. PubMed ID: 2879442
[TBL] [Abstract][Full Text] [Related]
31. Serologic dissection of HLA-D specificities by the use of monoclonal antibodies. II. Distinction between HLA-Dw2 and HLA-Dw12.
Kasahara M; Takenouchi T; Ikeda H; Ogasawara K; Okuyama T; Ishikawa N; Wakisaka A; Kikuchi Y; Aizawa M
Immunogenetics; 1983; 18(5):525-36. PubMed ID: 6196285
[TBL] [Abstract][Full Text] [Related]
32. DR2+ haplotypes in insulin-dependent diabetes: analysis of DNA restriction fragment length polymorphisms.
Segall M; Noreen H; Schluender L; Swenson M; Barbosa J; Bach FH
Hum Immunol; 1986 Sep; 17(1):61-8. PubMed ID: 3017902
[TBL] [Abstract][Full Text] [Related]
33. Sequencing of HLA-D in responders and nonresponders to short ragweed allergen, Amb a V.
Zwollo P; Ehrlich-Kautzky E; Scharf SJ; Ansari AA; Erlich HA; Marsh DG
Immunogenetics; 1991; 33(2):141-51. PubMed ID: 1999353
[TBL] [Abstract][Full Text] [Related]
34. DNA restriction fragment length polymorphism of HLA-DR2 haplotypes in normal individuals and in patients with rheumatoid arthritis.
Singal DP; Reid B; Green D; Bensen WG; D'Souza M
Ann Rheum Dis; 1990 Mar; 49(3):143-6. PubMed ID: 1969727
[TBL] [Abstract][Full Text] [Related]
35. Electrophoretic variation between class II molecules expressed on HLA-DRw8 homozygous typing cells reveals multiple distinct haplotypes.
Baldwin GC; Mickelson EM; Hansen JA; Nisperos B; Antonelli P; Nepom BS; Nepom GT
Immunogenetics; 1985; 21(1):49-60. PubMed ID: 3155707
[TBL] [Abstract][Full Text] [Related]
36. HLA-DR and DQ antigens in chronic lymphocytic leukemia: dissociation of expression revealed by cell surface, protein, and mRNA studies.
Kraïba R; Loiseau P; Faille A; Poirier O; Piatier-Tonneau D; Degos L; Abita JP; Charron D
Leukemia; 1989 May; 3(5):386-93. PubMed ID: 2497283
[TBL] [Abstract][Full Text] [Related]
37. Primary structure of human class II histocompatibility antigens 3rd communication. Amino acid sequence comparison between DR and DC subclass antigens derived from a lymphoblastoid B cell line homozygous at the HLA loci (HLA-A3,3; B7,7; Dw2,2; DR2,2: MT1,1; Dc1,1: MB1,1).
Götz H; Kratzin H; Thinnes FP; Yang C; Kruse T; Pauly E; Kölbel S; Egert G; Wernet P; Hilschmann N
Hoppe Seylers Z Physiol Chem; 1983 Jun; 364(6):749-55. PubMed ID: 6576979
[TBL] [Abstract][Full Text] [Related]
38. [HLA and narcolepsy. Apropos of 28 cases including 2 negative HLA-DR2].
Confavreux C; Gebuhrer L; Betuel H; Freidel C; Bastuji H; Jouvet M; Aimard G; Devic M
Rev Neurol (Paris); 1988; 144(5):327-31. PubMed ID: 3262232
[TBL] [Abstract][Full Text] [Related]
39. Highly polymorphic products of both HLA-DR and HLA-DQ genes contribute to the polymorphism of the HLA-DRw13 haplotype.
Michon J; Henin Y; Sterkers G; Freidel C; Gebuhrer L; Betuel H; Muller JY; Levy JP
Immunogenetics; 1986; 24(3):177-83. PubMed ID: 2428744
[TBL] [Abstract][Full Text] [Related]
40. The narcolepsy-associated DRw15,DQw6,Dw2 haplotype has no unique HLA-DQA or -DQB restriction fragments and does not extend to the HLA-DP subregion.
Olerup O; Schaffer M; Hillert J; Sachs C
Immunogenetics; 1990; 32(1):41-4. PubMed ID: 1973684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
